| Literature DB >> 10979858 |
Abstract
In developed countries as many as two individuals in every thousand suffer from inflammatory bowel disease (ulcerative colitis and Crohn's disease). In his Perspective, Shanahan discusses a new therapeutic approach to treating these conditions in which bacteria normally found in the gut are engineered to produce the anti-inflammatory cytokine interleukin-10 and then are fed as probiotics to mice with these disorders (Steidler et al.).Entities:
Mesh:
Substances:
Year: 2000 PMID: 10979858 DOI: 10.1126/science.289.5483.1311
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728